Researcher.Life Logo

Journal of Cardiovascular Translational Research : Impact Factor & More

eISSN: 1937-5395pISSN: 1937-5387

Aims and Scope of Journal of Cardiovascular Translational Research

The Journal of Cardiovascular Translational Research is a peer-reviewed medical journal covering all areas of cardiology. It is published by Springer Science+Business Media on behalf of the International Society for Cardiovascular Translational Research. It was established in 2008 and the editor-in-chief is Enrique Lara-Pezzi, CNIC, Madrid, Spain. Less

Key Metrics

CiteScore
5.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Cardiovascular Translational Research

Journal of Cardiovascular Translational Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • SJR SJR
Overview
Publisher SPRINGER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Cardiovascular Translational Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Cardiovascular Translational Research

Correction: The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy.
  • 28 Nov 2025
  • Journal of cardiovascular translational research
Gene Therapy for Inherited Cardiac Arrhythmias.
  • 30 Oct 2025
  • Journal of cardiovascular translational research
PFKFB3 Promotes Myofibroblast Differentiation and Cardiac Fibrosis Through its Intra- and Extra- Cellular Roles.
  • 30 Oct 2025
  • Journal of cardiovascular translational research
RNA Therapeutics in Heart Failure.
  • 30 Oct 2025
  • Journal of cardiovascular translational research
Des-Aspartate Angiotensin-1: A Dual-Targeted Therapeutic for Perivascular Inflammation and Vascular Dysfunction in Obesity.
  • 29 Oct 2025
  • Journal of cardiovascular translational research
A Potential Ratio for Detecting Subclinical Atherosclerosis: Insight into Advanced NMR Lipid Profiles in Severe Obesity.
  • 29 Oct 2025
  • Journal of cardiovascular translational research
Correction: The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy.
  • 28 Nov 2025
  • Journal of cardiovascular translational research
Gene Therapy for Inherited Cardiac Arrhythmias.
  • 30 Oct 2025
  • Journal of cardiovascular translational research
PFKFB3 Promotes Myofibroblast Differentiation and Cardiac Fibrosis Through its Intra- and Extra- Cellular Roles.
  • 30 Oct 2025
  • Journal of cardiovascular translational research
RNA Therapeutics in Heart Failure.
  • 30 Oct 2025
  • Journal of cardiovascular translational research
Des-Aspartate Angiotensin-1: A Dual-Targeted Therapeutic for Perivascular Inflammation and Vascular Dysfunction in Obesity.
  • 29 Oct 2025
  • Journal of cardiovascular translational research
A Potential Ratio for Detecting Subclinical Atherosclerosis: Insight into Advanced NMR Lipid Profiles in Severe Obesity.
  • 29 Oct 2025
  • Journal of cardiovascular translational research

FAQs on Journal of Cardiovascular Translational Research